Cytomegalovirus (CMV) management in allogeneic hematopoietic cell transplantation: Pre‐transplant predictors of survival, reactivation, and spontaneous clearanceJulian Lindsay, Matthew Greenwood, Chris Arthur et al.|Transplant Infectious Disease|2020Cited by 16
SUBA-Itraconazole for Primary Antifungal Prophylaxis After Allogeneic Hematopoietic Cell TransplantationJulian Lindsay, Monica A. Slavin, Sharon C.-A. Chen et al.|Open Forum Infectious Diseases|2021Cited by 15
Dynamics of Epstein–Barr virus on post‐transplant lymphoproliferative disorders after antithymocyte globulin‐conditioned allogeneic hematopoietic cell transplantJulian Lindsay, Monica A. Slavin, Chris Arthur et al.|Transplant Infectious Disease|2021Cited by 12
9 Clinical and endocopic improvement following hemopoietic stem cell transplantation in the ASTIC trialC J Hawkey, Séverine Vermeire, Lauren Clark et al.|Journal of Crohn s and Colitis|2013Cited by 11
Subtherapeutic concentrations of posaconazole tablet: determining risk factors and effectiveness of a standardized dose adjustment in hematology inpatientsJessica Bui, Julian Lindsay, Rochelle Gellatly et al.|Leukemia & lymphoma/Leukemia and lymphoma|2022Cited by 9